Results 161 to 170 of about 220,453 (316)

Emerging role of ARHGAP29 in melanoma cell phenotype switching

Molecular Oncology, EarlyView.
This study gives first insights into the role of ARHGAP29 in malignant melanoma. ARHGAP29 was revealed to be connected to tumor cell plasticity, promoting a mesenchymal‐like, invasive phenotype and driving tumor progression. Further, it modulates cell spreading by influencing RhoA/ROCK signaling and affects SMAD2 activity. Rho GTPase‐activating protein
Beatrice Charlotte Tröster, Melanie Kappelmann‐Fenzl, Anja Katrin Bosserhoff, Nicole Rachinger   +3 more
wiley   +1 more source

The Stellar Abundances and Galactic Evolution Survey (SAGES) III -- The g/r/i-band Data Release [PDF]

Chun Li, Fan Zhou, Gang Zhao, Wei Wang, Jie Zheng, Kefeng Tan, Jingkun Zhao, Yang Huang, Haibo Yuan, Kai Xiao, Yuqin Chen, Haining Li, Yujuan Liu, Nan Song, Ali Esamdin, Hubiao Niu, Jinzhong Liu, Guojie Feng   +17 more
openalex   +1 more source

Constraints on stellar evolution theory from precise eclipsing binary data [PDF]

, 1984
J. Andersen, J. V. Clausen, H.E. J⊘rgensen, B. Nordström   +3 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

Molecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici, Soheil Akbari, Ceyda Caliskan, Canan Celiker, Ozden Oz, Leman Binokay, Gökhan Karakulah, Serif Senturk, Esra Erdal   +8 more
wiley   +1 more source

APOKASC-3: The Third Joint Spectroscopic and Asteroseismic Catalog for Evolved Stars in the Kepler Fields

The Astrophysical Journal Supplement Series
In the third APOKASC catalog, we present data for the complete sample of 15,808 evolved stars with APOGEE spectroscopic parameters and Kepler asteroseismology.
Marc H. Pinsonneault, Joel C. Zinn, Jamie Tayar, Aldo Serenelli, Rafael A. García, Savita Mathur, Mathieu Vrard, Yvonne P. Elsworth, Benoit Mosser, Dennis Stello, Keaton J. Bell, Lisa Bugnet, Enrico Corsaro, Patrick Gaulme, Saskia Hekker, Marc Hon, Daniel Huber, Thomas Kallinger, Kaili Cao, Jennifer A. Johnson, Bastien Liagre, Rachel A. Patton, Ângela R. G. Santos, Sarbani Basu, Paul G. Beck, Timothy C. Beers, William J. Chaplin, Katia Cunha, Peter M. Frinchaboy, Léo Girardi, Diego Godoy-Rivera, Jon A. Holtzman, Henrik Jönsson, Szabolcs Mészáros, Claudia Reyes, Hans-Walter Rix, Matthew Shetrone, Verne V. Smith, Taylor Spoo, Keivan G. Stassun, Ji Wang   +40 more
doaj   +1 more source

The Eclipsing Binary V1061 Cygni: Confronting Stellar Evolution Models for Active and Inactive Solar‐Type Stars [PDF]

, 2006
Guillermo Torres, Claud H. Sandberg Lacy, Laurence A. Marschall, Holly A. Sheets, J. Mader   +4 more
openalex   +1 more source

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

Molecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert, Lauren van den Broecke, Osman Aksoy, Judith Lind, Sonia Vallet, Arne Van der Vreken, Gamze Ates, Ann Massie, Ken Maes, Kim De Veirman, Elke De Bruyne, Karin Vanderkerken, Klaus Podar, Eline Menu   +13 more
wiley   +1 more source

Stellar evolution [PDF]

Nature, 1968
openaire   +1 more source

Stellar evolution of compact stars in curvature–matter-coupling gravity [PDF]

, 2019
M. Sharif, Arfa Waseem
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

Molecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser, Jan Niklas Schäfer, Shraga Nahum Goldberg, Philipp Maximilian Kazmierczak, Moritz Nikolaus Gröper, Philipp Franz Linden, Elif Öcal, Tanja Burkard, Stefanie Corradini, Najib Ben Khaled, Moritz Wildgruber, Max Seidensticker, Jens Ricke, Matthias Stechele, Marianna Alunni‐Fabbroni   +14 more
wiley   +1 more source